CVS Health booked a third-quarter loss of more than $3 billion after setting aside money for a potential opioid litigation deal but still beat expectations and raised its 2022 forecast. CVS Health also recorded a $2.5 billion loss in the quarter on assets held for sale to write down the company’s struggling Omnicare long-term care business. CVS Health also saw …
